Details for New Drug Application (NDA): 050688
✉ Email this page to a colleague
NDA 050688 describes BANAN, which is a drug marketed by Sankyo and is included in two NDAs. Additional details are available on the BANAN profile page.
The generic ingredient in BANAN is cefpodoxime proxetil. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.
The generic ingredient in BANAN is cefpodoxime proxetil. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.
Summary for 050688
| Tradename: | BANAN |
| Applicant: | Sankyo |
| Ingredient: | cefpodoxime proxetil |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 100MG BASE/5ML | ||||
| Approval Date: | Aug 7, 1992 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 50MG BASE/5ML | ||||
| Approval Date: | Aug 7, 1992 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
